APA (7th ed.) Citation

Lorusso, D., Simonelli, M., Homicsko, K., Colombo, I., Kitano, S., Cassier, P., . . . Damian, S. (2025). 974P First-in-human phase I dose finding study of INCB123667, a selective CDK2 inhibitor, in patients with advanced solid tumors. Annals of Oncology, 36, S637. https://doi.org/10.1016/j.annonc.2025.08.1543

Chicago Style (17th ed.) Citation

Lorusso, D., et al. "974P First-in-human Phase I Dose Finding Study of INCB123667, a Selective CDK2 Inhibitor, in Patients with Advanced Solid Tumors." Annals of Oncology 36 (2025): S637. https://doi.org/10.1016/j.annonc.2025.08.1543.

MLA (9th ed.) Citation

Lorusso, D., et al. "974P First-in-human Phase I Dose Finding Study of INCB123667, a Selective CDK2 Inhibitor, in Patients with Advanced Solid Tumors." Annals of Oncology, vol. 36, 2025, p. S637, https://doi.org/10.1016/j.annonc.2025.08.1543.